Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1995-06-07
1998-12-01
Feisee, Lila
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
530359, 5303871, 5303881, 5303891, 435 71, C07K 1600, C07K 100, C07K 1400, C12P 2108
Patent
active
058440976
ABSTRACT:
Methods of diagnosing peripheral nerve damage, including diagnosing and monitoring chronic back and cervical pain are disclosed. The methods involve subjecting a body fluid sample from a patient suspected of having chronic lumbar or cervical pain and peripheral nerve damage to two-dimensional electrophoresis or an immunoassay and measuring relative amounts of protein or proteins which increase or decrease in concentration as compared to a standard control. A preferred method employs an Apo-E variant as a marker of peripheral nerve damage. Also disclosed are kits for use with the diagnostic methods.
REFERENCES:
patent: 3540850 (1970-11-01), Halpaap
patent: 3873433 (1975-03-01), Seidel et al.
patent: 3930983 (1976-01-01), Sieber
patent: 3979507 (1976-09-01), Baker
patent: 4118469 (1978-10-01), Caldwell et al.
patent: 4124470 (1978-11-01), Dahms
patent: 4178285 (1979-12-01), Felts et al.
patent: 4211530 (1980-07-01), Goverde et al.
patent: 4264589 (1981-04-01), Felts et al.
patent: 4311788 (1982-01-01), Heuck et al.
patent: 4416998 (1983-11-01), Adams et al.
patent: 4466951 (1984-08-01), Pittman et al.
patent: 4468466 (1984-08-01), Morrissey
patent: 4558007 (1985-12-01), Anderson et al.
patent: 4579735 (1986-04-01), Heimburger et al.
patent: 4579825 (1986-04-01), Siedel et al.
patent: 4603106 (1986-07-01), Cerami et al.
patent: 4619895 (1986-10-01), Cubicciotti et al.
patent: 4645748 (1987-02-01), Hurwitz et al.
patent: 4648974 (1987-03-01), Rosskopf et al.
patent: 4654301 (1987-03-01), Anderson et al.
patent: 4666578 (1987-05-01), Yamamoto
patent: 4677057 (1987-06-01), Curtiss et al.
patent: 4698298 (1987-10-01), Dedieu et al.
patent: 4708939 (1987-11-01), Siedel et al.
patent: 4722893 (1988-02-01), Shigeta et al.
patent: 4746605 (1988-05-01), Kerscher et al.
patent: 4772549 (1988-09-01), Fiossare
patent: 4778768 (1988-10-01), Heinegard et al.
patent: 4791066 (1988-12-01), Ishiguro
patent: 4820505 (1989-04-01), Ginsberg et al.
patent: 4822776 (1989-04-01), Cerami et al.
patent: 4828986 (1989-05-01), Smith et al.
patent: 4877746 (1989-10-01), Jansson et al.
patent: 4892814 (1990-01-01), Harrington et al.
patent: 4892815 (1990-01-01), Kerscher et al.
patent: 4895558 (1990-01-01), Cham
patent: 4920115 (1990-04-01), Nestler et al.
patent: 4923439 (1990-05-01), Seidel et al.
patent: 4935363 (1990-06-01), Brown et al.
patent: 4943522 (1990-07-01), Eisinger et al.
patent: 4943527 (1990-07-01), Protter et al.
patent: 4945040 (1990-07-01), Fless et al.
patent: 4948723 (1990-08-01), Hermon-Taylor et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 4970144 (1990-11-01), Fareed et al.
patent: 4973638 (1990-11-01), Sparrow et al.
patent: 4975528 (1990-12-01), Kaminski et al.
patent: 4978503 (1990-12-01), Shanks et al.
patent: 4997916 (1991-03-01), Aviv et al.
patent: 5030722 (1991-07-01), Snyder et al.
patent: 5032511 (1991-07-01), Takahashi et al.
patent: 5045480 (1991-09-01), Johnson et al.
patent: 5049488 (1991-09-01), Baer et al.
patent: 5055396 (1991-10-01), Curtiss et al.
patent: 5059528 (1991-10-01), Bollen et al.
patent: 5064769 (1991-11-01), Gambert et al.
patent: 5089602 (1992-02-01), Iskiker et al.
Atlantic Antibodies, "Apolipoprotein E test kit", in The Medical Observer, vol. 21, p. 16, 1989.
VanderPutten et al, "Increased apolipoprotein-E concentrations in individuals suffering chronic low back syndrome identified by two-dimensional gel electrophoresis", Applied and Theoretical Electrophoresis, vol. 3, pp. 247-252, Oct. 13, 1993.
Carlsson et al, "Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid" Clinica Chimica Acta, vol. 196, pp. 167-176, 1991.
Basu et al., Proc. Natl. Acad. Sci. USA, vol. 78, No. 12, pp. 7545-7549 Dec. 1981.
Basu et al., Science, vol. 219, Feb., 1983, pp. 871-873.
Boyles et al., J. Clin. Invest, vol. 76, Oct. 1985, 1501-1513.
Boyles et al., J. Clin. Invest, vol. 83, Mar. 1989, 1015-1031.
Boyles et al., J. Biol. Chem., vol. 265, No. 29, Oct., 1990, pp. 17805-17815.
Breslow, Ann. Rev. Biochem. 1985, 54:699-727.
Cuthbert et al., Proc. Natl. Acad. Sci. USA, vol. 81, pp. 4539-4543, Jul., 1984.
Elshourbagy et al., Proc. Natl. Acad. Sci. USA, vol. 82, pp. 203-207, Jan., 1985.
Folkman et al., Nature, vol. 273, Jun. 1, 1978 pp. 345-349.
Frohlich et al., Clin. Biohem., vol. 22, pp. 51-56, 1989.
Hallman et al., Am. J. Hum. Genet. 49:338-349, 1991.
Kostner, Biochemical Society Transactions, 629th Meeting, London, vol. 17, pp. 639-641.
Lalazar et al., J. Biol. Chem., vol. 264,No. 15, May 25, 1989, pp. 8447-8450.
Mahley, Science, vol. 240, Apr. 1988, pp. 622-630.
Majack et al., J. Cell. Biol., vol. 107, Sep. 1988, 1207-1213.
Menzel et al., Electrophoresis 1986, 7, 492-495.
Muller et al., Journal of Neuroscience Research 18:222:229 (1987).
Pitas, J. Biol. Chem, vol. 262, No. 29, Oct. 15, 1987, pp. 14352-14360.
Pitas et al., Biochimica et Biophysica Acta 917 (1987) 148-161.
Rall, Jr. et al., J. Clin. Invest., vol. 83, Apr. 1989, pp. 1095-1101.
Roheim et al., Proc. Natl. Acad. Sci. USA, vol. 76, No. 9, pp. 4646-4649 Sep., 1979.
Roheim et al., European Heart Journal (1990) 11 (Supplement E), 225-229.
Ross, The New England Journal of Medicine, vol., 314, No. 8, Feb. 20, 1986, pp. 488-500.
Snipes et al., Proc Natl. Acad. Sci. USA, vol. 83, pp. 1130-1134, Feb., 1986, Neurobiology.
Sprecher et al., Clin. Chem. 30/12, 2084-2092 (1984).
Utermann et al., J. Lipid Research, vol. 25, 1984, pp. 378-382.
Weisgraber et al., J. Biol. Chem., vol. 257, No. 5, Mar. 10, 1982, pp. 2518-2521.
Weisgraber et al., Biochemical and Biophysical Research Communications, vol., 157, No. 3, 1988, pp. 1212-1217.
Werb et al., J. Exp. Med., vol. 158, Oct., 1983, pp. 1272-1293.
Wilson et al., Science, vol. 252, Jun. 28, 1991, pp. 1817-1822.
Zannis et al., Biochemistry, vol. 20, No. 4, 1981, pp. 1033-1041.
Zannis et al., J. Lipid Research, vol. 23, 1982, pp. 911-914.
Ahonen et al., Acta Neurologica Scandinavica, vol. 58, Fasc. 6 (1978) 358-365.
Felgenhauer et al., Clinica Chimica Acta, 100 (1980) pp. 121-132.
Frot et al., Marker Proteins in Inflammation, pp. 253-273 (1982).
Harrington et al., Clin. Chem. vol. 30, No. 12, pp. 1933-1937 (1982).
Kushner, Annals of the New York Acad. of Sci., pp. 39-48 (1982).
McCarty, Annals of the New York Acad. of Sci., pp. 1-10 (1982).
Merril et al., Clin. Chem. vol. 28, No. 4, pp. 1015-1020 (1982).
Tracy et al., Clin. Chem. vol. 28, No. 4, pp. 890-899 (1982).
Tracy et al., Clin. Chem. vol. 28, No. 4, pp. 900-907 (1982).
Tracy et al., Clin. Chem. vol. 28, No. 4, pp. 915-919 (1982).
Tracy et al., J. Clin. Laboratory Automation, vol. 3, No. 4, (1983) pp. 235-243.
Varma et al., Experimental Cell Research 173 (1987) pp. 163-173.
Willard et al., Clin. Chem. vol. 28, No. 4, pp. 1067-1073 (1982).
Havel et al., "Lipoproteins and Lipid Transport" in Metabolic Control and Diseases, pp. 393-494 (1980).
Hui et al., J. Biol. Chem., pp. 11775-11781 (1980).
Hochstrasser et al., Applied & Theoretical Electro., pp. 73-76 (1988).
Ignatius et al., Science, vol. 236, pp. 959-962 (1987).
Ignatius et al., PNAS USA, vol. 83, pp. 1125-1129 (1986).
Ignatius et al., Prog. in Brain Res., vol. 71, pp. 177-184 (1987).
Carlsson, et al., Clinica Chimica Acta, "Clinical relevance of the gantification of apoliprotein E in cerebrospinal fluid", vol. 196, (1991) pp. 167-176.
Harrel, et al., Biochem. BIophys. Aeta, 573:175-183, 1979.
Horie, et al., The Functional Characteristics of Human Apolipoprotein F. Variant (Cysteine at Residue 142), May Explain Its Association with Dominant Expression of Type III Hyperlipoprotemia, JBC 267 (3) 1962-1968 (1992).
Lettimaki, et al., Association of Apolipoprotein E and B Polymorphism w/Serum Lipids, Ann. Med., 23:657-662 1991.
Xhignesse, et al., Influence as of Common Variants of Apol-protein E on on Measures of Lipid Metabolis in a Sample Selected for Health, Arteriosclter. Thromb. 11(4):1100-1110 (1991).
Cameron, Sr. Bruce M.
Creed Guy Joseph
Merril Carl R.
VanderPutten Dale
Eyler Yvonne
Feisee Lila
Monoclonetics International, Inc.
LandOfFree
Methods for the diagnosis of peripheral nerve damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the diagnosis of peripheral nerve damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the diagnosis of peripheral nerve damage will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2396721